文献
J-GLOBAL ID:202002248284774689
整理番号:20A1001861
アポリポ蛋白質A-I濃度と冠動脈疾患リスク:メンデル無作為化研究【JST・京大機械翻訳】
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
著者 (42件):
Karjalainen Minna K.
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Karjalainen Minna K.
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Karjalainen Minna K.
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Holmes Michael V.
(Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK)
,
Holmes Michael V.
(Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK)
,
Holmes Michael V.
(National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospital, Oxford, UK)
,
Holmes Michael V.
(Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK)
,
Wang Qin
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Wang Qin
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Wang Qin
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Wang Qin
(Systems Epidemiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia)
,
Anufrieva Olga
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Anufrieva Olga
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Anufrieva Olga
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Kaehonen Mika
(Department of Clinical Physiology, Tampere University Hospital, and Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
,
Lehtimaeki Terho
(Department of Clinical Chemistry, Fimlab Laboratoriesand Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
,
Havulinna Aki S.
(National Institute for Health and Welfare, Helsinki, Finland)
,
Havulinna Aki S.
(Institute for Molecular Medicine Finland (FIMM-HiLIFE), Helsinki, Finland)
,
Kristiansson Kati
(National Institute for Health and Welfare, Helsinki, Finland)
,
Salomaa Veikko
(National Institute for Health and Welfare, Helsinki, Finland)
,
Perola Markus
(National Institute for Health and Welfare, Helsinki, Finland)
,
Perola Markus
(Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland)
,
Perola Markus
(Estonian Genome Center, University of Tartu, Tartu, Estonia)
,
Viikari Jorma S.
(Department of Medicine, University of Turku, Turku, Finland)
,
Viikari Jorma S.
(Division of Medicine, Turku University Hospital, Turku, Finland)
,
Raitakari Olli T.
(Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland)
,
Raitakari Olli T.
(Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland)
,
Raitakari Olli T.
(Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland)
,
Jaervelin Marjo-Riitta
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Jaervelin Marjo-Riitta
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Jaervelin Marjo-Riitta
(Unit of Primary Health Care, Oulu University Hospital, OYS, Oulu, Finland)
,
Jaervelin Marjo-Riitta
(Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK)
,
Jaervelin Marjo-Riitta
(Department of Life Sciences, College of Health and Life Sciences, Brunel University London, UK)
,
Ala-Korpela Mika
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Ala-Korpela Mika
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Ala-Korpela Mika
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Ala-Korpela Mika
(NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland)
,
Ala-Korpela Mika
(Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, The Alfred Hospital, Monash University, Melbourne, VIC, Australia)
,
Kettunen Johannes
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Kettunen Johannes
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
,
Kettunen Johannes
(Biocenter Oulu, University of Oulu, Oulu, Finland)
,
Kettunen Johannes
(National Institute for Health and Welfare, Helsinki, Finland)
資料名:
Atherosclerosis
(Atherosclerosis)
巻:
299
ページ:
56-63
発行年:
2020年
JST資料番号:
E0599B
ISSN:
0021-9150
CODEN:
ATHSBL
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)